EyeGate Pharma Acquires Jade Therapeutics
Mar 07, 2016 21:05 pm UTC| Business
Transaction enhances development pipeline with addition of new ophthalmic platform technology. First Jade product to enter clinic later this year.WALTHAM, Mass., March 07, 2016 -- Eyegate Pharmaceuticals, Inc....
Newtek Business Services Corp. Reports Full Year 2015 Financial Results
Mar 07, 2016 21:05 pm UTC| Business
NEW YORK, March 07, 2016 -- Newtek Business Services Corp. (“Newtek” or the “Company”), (NASDAQ:NEWT), an internally managed business development company (“BDC”), announced today its financial results for the year ended...
Aduro Biotech to Present at ROTH Conference
Mar 07, 2016 21:05 pm UTC| Business
BERKELEY, Calif., March 07, 2016 -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the 28th Annual ROTH Conference in...
Francois Dufresne Appointed to Noodles & Company Board of Directors
Mar 07, 2016 21:05 pm UTC| Business
BROOMFIELD, Colo., March 07, 2016 -- Noodles Company (NASDAQ:NDLS) today announced the appointment of François Dufresne, Senior Director at the Public Sector Pension Investment Board ("PSP Investments"), to its Board...
Five9 to Present at the 28th Annual ROTH Conference on March 15, 2016
Mar 07, 2016 21:05 pm UTC| Business
SAN RAMON, Calif., March 07, 2016 -- Five9, Inc. (NASDAQ:FIVN), a leading provider of cloud software for the enterprise contact center market, announced today that members of its management team will present at the 28th...
Vical Announces News Release and Conference Call Schedule for Fourth Quarter 2015 Financial Results
Mar 07, 2016 21:05 pm UTC| Business
SAN DIEGO, March 07, 2016 -- Vical Incorporated (Nasdaq:VICL) today announced that the company will report financial results for the three and twelve months ended December 31, 2015, before the opening of trading on...
Heat Biologics Presents Positive ComPACT Preclinical Data at the Keystone Symposia
Mar 07, 2016 21:05 pm UTC| Business
DURHAM, N.C., March 07, 2016 -- Heat Biologics, Inc. (“Heat”) (Nasdaq:HTBX), an immuno-oncology company developing novel therapies that activate a patient’s immune system against cancer, announced that positive...